SOTAC PHARMACEUTICALS
|
The Current P/E Ratio of SOTAC PHARMACEUTICALS is 42.94.
Share Price | ₹115.0 | May 30,2024 |
Market Cap | ₹127.7 Cr | |
Earnings-TTM | ₹3.0 Cr | TTM-Consolidated Results |
Price/Earnings | 42.94x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SOTAC PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹127.7 Cr] as on May 30,2024
(/) Earnings [ ₹3.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 42.94x ]
Thus, for SOTAC PHARMACEUTICALS , the investors are currently willing to pay 42.94 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SOTAC PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SOTAC PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SOTAC PHARMACEUTICALS
PE Ratio Performance Analysis for SOTAC PHARMACEUTICALS
- SOTAC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2020 averaged 0.00x.
- SOTAC PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, SOTAC PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 0x.
- SOTAC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SOTAC PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SOTAC PHARMACEUTICALS | 2.97 | 42.94 | 127.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 9,648.44 | 36.31 | 350,339.0 |
CIPLA LTD | 4,155.31 | 28.14 | 116,930.0 |
DR REDDYS LABORATORIES LTD | 5,563.20 | 17.35 | 96,546.9 |
ZYDUS LIFESCIENCES LTD | 3,831.40 | 26.28 | 100,694.0 |
DIVIS LABORATORIES LTD | 1,600.00 | 71.51 | 114,416.0 |
MANKIND PHARMA LTD | 1,926.55 | 44.63 | 85,978.3 |
TORRENT PHARMACEUTICALS LTD | 1,656.00 | 55.11 | 91,258.4 |
LUPIN LTD | 1,935.57 | 37.40 | 72,388.0 |
AUROBINDO PHARMA LTD | 3,186.13 | 21.83 | 69,550.9 |
ABBOTT INDIA LTD | 1,201.22 | 45.77 | 54,984.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SOTAC PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.35x |
Max industry PE | 71.51x |
Median industry PE | 37.40x |
Average industry PE | 38.84x |
You may also like the below Video Courses